These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 33116979)

  • 1. Evidence-Based Framework and Implementation of China's Strategy in Combating COVID-19.
    Zhao D; Lin H; Zhang Z
    Risk Manag Healthc Policy; 2020; 13():1989-1998. PubMed ID: 33116979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What determines city's resilience against epidemic outbreak: evidence from China's COVID-19 experience.
    Chen J; Guo X; Pan H; Zhong S
    Sustain Cities Soc; 2021 Jul; 70():102892. PubMed ID: 33816083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 control strategies in Taizhou city, China.
    Lin H; Guo C; Hu Y; Liang H; Shen W; Mao W; He N
    Bull World Health Organ; 2020 Sep; 98(9):632-637. PubMed ID: 33012863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological profile of dengue in Zhejiang Province, southeast China.
    Ren J; Ling F; Sun J; Gong Z; Liu Y; Shi X; Zhang R; Zhai Y; Chen E; Chen Z
    PLoS One; 2018; 13(12):e0208810. PubMed ID: 30533054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise Community-Based Public Health Management: Crucial Experience Responding to COVID-19 in Wuhan, China.
    Ran L; Tan X; Zhang Y
    Risk Manag Healthc Policy; 2022; 15():171-178. PubMed ID: 35173495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. China's experience in COVID-19 prevention and control among children in its different regions.
    Luo Q; Yuan L; Zhang J; Wei W; Xiang W; Shao JB; Fan LC; Li L; Zhai XW; Zhang XB; Zhou AF; Huang GY; Gu S
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10867-10873. PubMed ID: 33155249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. City lockdown and nationwide intensive community screening are effective in controlling the COVID-19 epidemic: Analysis based on a modified SIR model.
    Peng T; Liu X; Ni H; Cui Z; Du L
    PLoS One; 2020; 15(8):e0238411. PubMed ID: 32857824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does city lockdown prevent the spread of COVID-19? New evidence from the synthetic control method.
    Yang X
    Glob Health Res Policy; 2021 Jul; 6(1):20. PubMed ID: 34193312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological Investigation and Prevention Control Analysis of the Longitudinal Distribution of COVID-19 in Henan Province, China.
    Yang X; Chen X; Ding C; Bai Z; Zhu J; Sun G; Yu G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33028688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fangcang shelter hospitals are a One Health approach for responding to the COVID-19 outbreak in Wuhan, China.
    Wang KW; Gao J; Song XX; Huang J; Wang H; Wu XL; Yuan QF; Li XS; Cheng F; Cheng Y
    One Health; 2020 Dec; 10():100167. PubMed ID: 33117879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From blanket quarantine in Wuhan to distant centralized quarantine in Shijiazhuang: the evolution of China's COVID-19 quarantine approach.
    Wang B; Zheng H
    Infection; 2021 Aug; 49(4):765-767. PubMed ID: 33961272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building community-centered social infrastructure: a feminist inquiry into China's COVID-19 experiences.
    Li Z; Chen Y; Zhan Y
    Econ Polit (Bologna); 2022; 39(1):303-321. PubMed ID: 35422592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of patients with COVID-19 from a designated hospital in Hangzhou City: a retrospective observational study.
    Gao J; Zhang S; Zhou K; Zhao X; Liu J; Pu Z
    Hong Kong Med J; 2022 Feb; 28(1):54-63. PubMed ID: 33177240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taizhou's COVID-19 prevention and control experience with telemedicine features.
    Shao C; Li S; Zhu F; Zhao D; Shao H; Chen H; Zhang Z
    Front Med; 2020 Aug; 14(4):506-510. PubMed ID: 32862396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 outbreak prevention by early containment in Shantou, China.
    Zhang X; Zhang D; Zhang C; Yao L; Xu L; Chen G; Liao Z; Zhu X; Yang W; Li W
    J Infect Dev Ctries; 2020 Jul; 14(7):742-747. PubMed ID: 32794464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population migration, confirmed COVID-19 cases, pandemic prevention, and control: evidence and experiences from China.
    Yang H; Hu S; Zheng X; Wu Y; Lin X; Xie L; Shen Z
    Z Gesundh Wiss; 2022; 30(5):1257-1263. PubMed ID: 33134036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
    Wu J; Liu J; Li S; Peng Z; Xiao Z; Wang X; Yan R; Luo J
    Travel Med Infect Dis; 2020; 37():101673. PubMed ID: 32311437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COVID-19 case report from asymptomatic contact: implication for contact isolation and incubation management.
    Zhu CQ; Gao SD; Xu Y; Yang XH; Ye FQ; Ai LL; Lv RC; Zhang B; Li Y; Lv H; Liu YS; Shi CM; Wang CH; Tan WL
    Infect Dis Poverty; 2020 Jun; 9(1):70. PubMed ID: 32560671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.